A breakthrough in Russia promises to redefine cancer treatment, with the country announcing its first mRNA cancer vaccine.
The addition of lenvatinib/pembrolizumab to TACE showed a numerical improvement in PFS, but longer follow-up is necessary to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback